HMGB1 and thrombophilia: Our findings suggest that increased thrombin generation in sepsis or other inflammatory diseases associated with hypercoagulability could lead to overzealous production of platelet-derived HMGB1, previously shown to be associated with morbidity and mortality in human septic patients.